HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of the L/N-type calcium channel antagonist cilnidipine on morning blood pressure control and peripheral edema formation.

Abstract
The L/N-type calcium channel blocker cilnidipine has unique effects including sympathetic nerve suppression and the balanced vasodilatation of arteries and veins that may alleviate morning hypertension (MHT) or peripheral edema caused by calcium channel antagonists. We used ambulatory blood pressure monitoring (ABPM) and a unique peripheral edema measurement to evaluate the effect of morning and bedtime cilnidipine in patients with MHT. Forty-three patients with MHT (60 ± 12 years) were randomly assigned to a morning or bedtime cilnidipine (10-20 mg/day). MHT was defined as a mean systolic blood pressure (SBP) ≥ 135 mm Hg by ABPM within 2 hours after awaking. After 3 months, greater SBP reductions were observed in the bedtime administration group (versus the morning administration group) at 3:30-6:00 AM (-24 ± 20 mm Hg vs. -10 ± 4 mm Hg; P < .05) and at 6:30-9:00 AM (-26 ± 15 mm Hg vs. -14 ± 17 mm Hg; P < .05). Although physical examinations showed leg edema in 16% of the patients, quantitative evaluations did not reveal significant volume gains. Cilnidipine had a greater effect on MHT, without causing significant leg edema, when administered at bedtime.
AuthorsSumito Narita, Yasuko Yoshioka, Atsumi Ide, Toshiaki Kadokami, Hidetoshi Momii, Masayoshi Yoshida, Shin-ichi Ando
JournalJournal of the American Society of Hypertension : JASH (J Am Soc Hypertens) 2011 Sep-Oct Vol. 5 Issue 5 Pg. 410-6 ISSN: 1933-1711 [Print] United States
PMID21640687 (Publication Type: Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2011 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Calcium Channel Blockers
  • Dihydropyridines
  • cilnidipine
Topics
  • Aged
  • Blood Pressure (drug effects)
  • Blood Pressure Monitoring, Ambulatory
  • Calcium Channel Blockers (pharmacology)
  • Dihydropyridines (pharmacology)
  • Edema (prevention & control)
  • Female
  • Heart Rate (drug effects)
  • Humans
  • Hypertension (complications, prevention & control)
  • Leg
  • Male
  • Middle Aged
  • Sympathetic Nervous System (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: